Barrons.com23h agoneutral
Novo Stock Rises After Earnings. It’s Taking the Weight-Loss Drug Fight to Eli Lilly.Novo Nordisk stock rose as it raised its guidance on the back of the strong performance of its weight-loss pill.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Novo Nordisk stock rose as it raised its guidance on the back of the strong performance of its weight-loss pill.
May 6 (Reuters) - European shares rose on Tuesday, with oil prices dropping and investor optimism rising after U.S.